Who
Eric H. Rubin
Director
Company insider
Files Form 4 as: Director, Natera; Director, Oncorus.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 16 Jun 2021
- Last trade
- 26 Jun 2026
- Last filed
- 30 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jun 2026filed 30 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —75 | filing |
| 26 Jun 2026filed 30 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —75 | filing |
| 29 May 2026filed 3 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —2,124 | filing |
| 29 May 2026filed 3 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —2,124 | filing |
| 24 Apr 2026filed 28 Apr 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —5 | filing |
| 24 Apr 2026filed 28 Apr 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —5 | filing |
| 23 Jun 2022filed 24 Jun 2022 | Oncorusoption or derivative | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 16 Jun 2021filed 17 Jun 2021 | Oncorusoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.